Acute Pain Epidemiology Forecast

DelveInsight's 'Acute Pain - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Acute Pain epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Acute Pain Understanding

The DelveInsight Acute Pain epidemiology report gives a thorough understanding of the Acute Pain by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Acute Pain in the US, Europe, and Japan. The report covers the detailed information of the Acute Pain epidemiology scenario in seven major countries (US, EU5, and Japan).


Acute Pain Epidemiology Perspective by DelveInsight

The Acute Pain epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Acute Pain epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Acute Pain epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Acute Pain Detailed Epidemiology Segmentation

The Acute Pain epidemiology covered in the report provides historical as well as forecasted Acute Pain epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Acute Pain report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Acute Pain Epidemiology forecastScope of the Report

  • The Acute Pain report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Acute Pain Epidemiology Report and Model provide an overview of the risk factors and global trends of Acute Pain in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Acute Pain in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Acute Pain
  • The report provides the segmentation of the Acute Pain epidemiology


Report Highlights

  • 11-Year Forecast of Acute Pain epidemiology
  • 7MM Coverage
  • Total Cases of Acute Pain
  • Total Cases of Acute Pain according to segmentation
  • Diagnosed cases of Acute Pain


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Acute Pain?
  • What are the key findings pertaining to the Acute Pain epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Acute Pain across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Acute Pain?
  • What are the currently available treatments of Acute Pain?


Reasons to buy

  • The Acute Pain Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Acute Pain market
  • Quantify patient populations in the global Acute Pain market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Acute Pain therapeutics in each of the markets covered
  • Understand the magnitude of Acute Pain population by its epidemiology
  • The Acute Pain Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Acute Pain

3. Acute Pain: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Acute Pain Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Acute Pain Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Acute Pain Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Acute Pain Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Acute Pain Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Acute Pain Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Acute Pain Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Acute Pain Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Acute Pain Treatment and Management

6.2. Acute Pain Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Acute Pain Epidemiology in 7MM (2017-2030)

Table 2 Acute Pain Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Acute Pain Epidemiology in the United States (2017-2030)

Table 4 Acute Pain Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Acute Pain Epidemiology in Germany (2017-2030)

Table 6 Acute Pain Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Acute Pain Epidemiology in France (2017-2030)

Table 8 Acute Pain Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Acute Pain Epidemiology in Italy (2017-2030)

Table 10 Acute Pain Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Acute Pain Epidemiology in Spain (2017-2030)

Table 12 Acute Pain Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Acute Pain Epidemiology in the United Kingdom (2017-2030)

Table 14 Acute Pain Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Acute Pain Epidemiology in Japan (2017-2030)

Table 16 Acute Pain Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Acute Pain Epidemiology in 7MM (2017-2030)

Figure 2 Acute Pain Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Acute Pain Epidemiology in the United States (2017-2030)

Figure 4 Acute Pain Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Acute Pain Epidemiology in Germany (2017-2030)

Figure 6 Acute Pain Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Acute Pain Epidemiology in France (2017-2030)

Figure 8 Acute Pain Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Acute Pain Epidemiology in Italy (2017-2030)

Figure 10 Acute Pain Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Acute Pain Epidemiology in Spain (2017-2030)

Figure 12 Acute Pain Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Acute Pain Epidemiology in the United Kingdom (2017-2030)

Figure 14 Acute Pain Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Acute Pain Epidemiology in Japan (2017-2030)

Figure 16 Acute Pain Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report


  • Tags:
  • Acute Pain Epidemiology
  • Acute Pain
  • Acute Pain Pipeline
  • Acute Pain Companies
  • Acute Pain prevalent population
  • Acute Pain incident population
  • Acute Pain patients diagnosed
  • Acute Pain treatment algorithm

Forward to Friend

Need A Quote